(R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [MB modified form results in decreased secretion of very low density lipoprotein triglyceride] CTD PMID:17478120 17alpha-ethynylestradiol multiple interactions ISO RGD:1552831 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MB mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1552831 6480464 Ethinyl Estradiol results in increased expression of MB mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1552831 6480464 Ethinyl Estradiol affects the expression of MB mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:1354197 6480464 Estradiol results in decreased expression of MB mRNA CTD PMID:19619570 , PMID:25321415 17beta-estradiol decreases expression ISO RGD:1552831 6480464 Estradiol results in decreased expression of MB mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1354197 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MB mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1354197 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MB mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MB mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552831 6480464 Tetrachlorodibenzodioxin affects the expression of MB mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354197 6480464 Tetrachlorodibenzodioxin results in increased expression of MB mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1354197 6480464 Tetrachlorodibenzodioxin affects the expression of MB mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552831 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MB mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1354197 6480464 Tetrachlorodibenzodioxin results in decreased expression of MB mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of MB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of MB mRNA CTD PMID:21346803 4,4'-sulfonyldiphenol increases expression ISO RGD:1552831 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MB mRNA CTD PMID:30951980 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of MB mRNA CTD PMID:21346803 acetamiprid decreases expression EXP 6480464 acetamiprid results in decreased expression of MB mRNA CTD PMID:27782041 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MB mRNA CTD PMID:28606764 , PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1354197 6480464 Aflatoxin B1 results in decreased expression of MB mRNA CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:1354197 6480464 aflatoxin B2 results in increased methylation of MB intron CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MB mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MB mRNA CTD PMID:30779732 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of MB protein CTD PMID:27815113 atorvastatin calcium multiple interactions ISO RGD:1552831 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased secretion of MB protein CTD PMID:29679711 atrazine increases expression ISO RGD:1354197 6480464 Atrazine results in increased expression of MB protein CTD PMID:1916698 benzo[a]pyrene decreases expression ISO RGD:1552831 6480464 Benzo(a)pyrene results in decreased expression of MB mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1354197 6480464 Benzo(a)pyrene affects the methylation of MB intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1354197 6480464 Benzo(a)pyrene results in decreased methylation of MB 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1354197 6480464 Benzo(a)pyrene results in increased methylation of MB exon, Benzo(a)pyrene results in increased methylation of MB promoter CTD PMID:27901495 benzo[e]pyrene increases methylation ISO RGD:1354197 6480464 benzo(e)pyrene results in increased methylation of MB intron CTD PMID:30157460 Benzo[k]fluoranthene increases expression ISO RGD:1552831 6480464 benzo(k)fluoranthene results in increased expression of MB mRNA CTD PMID:26377693 bisphenol A decreases expression ISO RGD:1354197 6480464 bisphenol A results in decreased expression of MB mRNA CTD PMID:33476716 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MB mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of MB gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MB mRNA CTD PMID:25181051 , PMID:27178563 bisphenol F increases expression ISO RGD:1552831 6480464 bisphenol F results in increased expression of MB mRNA CTD PMID:30951980 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of MB mRNA CTD PMID:32479839 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MB mRNA CTD PMID:19167457 carbon nanotube affects expression ISO RGD:1552831 6480464 Nanotubes, Carbon analog affects the expression of MB mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1552831 6480464 Nanotubes, Carbon results in decreased expression of MB mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1552831 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carvacrol multiple interactions EXP 6480464 carvacrol inhibits the reaction [Poloxamer results in increased secretion of MB protein] CTD PMID:29071762 cerium trichloride increases expression ISO RGD:1354197 6480464 cerous chloride results in increased expression of MB mRNA CTD PMID:28954213 cerium trichloride multiple interactions ISO RGD:1354197 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of MB mRNA CTD PMID:28954213 cerivastatin increases secretion EXP 6480464 cerivastatin results in increased secretion of MB protein CTD PMID:19628585 CGP 52608 multiple interactions ISO RGD:1354197 6480464 CGP 52608 promotes the reaction [RORA protein binds to MB gene] CTD PMID:28238834 ciprofloxacin multiple interactions ISO RGD:1552831 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased secretion of MB protein CTD PMID:29679711 clofibrate multiple interactions ISO RGD:1552831 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MB mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MB mRNA] CTD PMID:17585979 cobalt dichloride increases secretion EXP 6480464 cobaltous chloride results in increased secretion of MB protein CTD PMID:19628585 copper atom decreases expression ISO RGD:1354197 6480464 Copper deficiency results in decreased expression of MB protein CTD PMID:24708542 copper(0) decreases expression ISO RGD:1354197 6480464 Copper deficiency results in decreased expression of MB protein CTD PMID:24708542 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of MB mRNA CTD PMID:15755911 cumene hydroperoxide affects metabolic processing ISO RGD:1354197 6480464 MB protein mutant form affects the metabolism of cumene hydroperoxide CTD PMID:8855949 cypermethrin increases expression ISO RGD:1552831 6480464 cypermethrin results in increased expression of MB mRNA CTD PMID:21142847 dexamethasone decreases expression ISO RGD:1552831 6480464 Dexamethasone results in decreased expression of MB protein CTD PMID:33567340 dioxygen affects transport ISO RGD:1552831 6480464 MB protein affects the transport of Oxygen CTD PMID:10468637 dioxygen multiple interactions ISO RGD:1552831 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MB mRNA CTD PMID:30529165 dobutamine affects response to substance ISO RGD:1552831 6480464 MB protein affects the susceptibility to Dobutamine CTD PMID:10468637 dorsomorphin multiple interactions ISO RGD:1354197 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MB mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1552831 6480464 [Doxorubicin co-treated with MT2A protein] results in decreased expression of MB protein, sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of MB protein] CTD PMID:16144979 , PMID:21251210 doxorubicin decreases expression ISO RGD:1354197 6480464 Doxorubicin results in decreased expression of MB mRNA CTD PMID:28940058 , PMID:29803840 doxorubicin increases expression ISO RGD:1552831 6480464 Doxorubicin results in increased expression of MB protein CTD PMID:21251210 Echimidine decreases expression EXP 6480464 echimidine results in decreased expression of MB mRNA CTD PMID:34185104 entinostat increases expression ISO RGD:1354197 6480464 entinostat results in increased expression of MB mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1354197 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MB mRNA CTD PMID:27188386 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MB protein CTD PMID:23200777 gallic acid decreases expression ISO RGD:1354197 6480464 Gallic Acid results in decreased expression of MB mRNA CTD PMID:34408198 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of MB gene CTD PMID:28505145 genistein decreases expression ISO RGD:1552831 6480464 Genistein results in decreased expression of MB mRNA CTD PMID:32186404 glycerol increases expression EXP 6480464 Glycerol results in increased expression of MB protein CTD PMID:27329933 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of MB mRNA CTD PMID:27916585 graphite increases expression ISO RGD:1552831 6480464 Graphite results in increased expression of MB mRNA CTD PMID:27440207 Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of MB mRNA CTD PMID:34185104 hydrogen peroxide increases activity ISO RGD:1354197 6480464 Hydrogen Peroxide results in increased activity of MB protein mutant form CTD PMID:8855949 imidacloprid decreases expression EXP 6480464 imidacloprid results in decreased expression of MB mRNA CTD PMID:27782041 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1552831 6480464 indeno(1 more ... CTD PMID:26377693 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of MB protein CTD PMID:32627257 , PMID:533011 isoprenaline multiple interactions EXP 6480464 sinapinic acid inhibits the reaction [Isoproterenol results in increased expression of MB protein] CTD PMID:32627257 isoprenaline increases secretion EXP 6480464 Isoproterenol results in increased secretion of MB protein CTD PMID:19628585 ivermectin decreases expression ISO RGD:1354197 6480464 Ivermectin results in decreased expression of MB protein CTD PMID:32959892 lead diacetate decreases expression ISO RGD:1552831 6480464 lead acetate results in decreased expression of MB mRNA CTD PMID:22609695 , PMID:29746905 lipopolysaccharide multiple interactions ISO RGD:1354197 6480464 [S-(1 more ... CTD PMID:20699433 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:1354197 6480464 Lipopolysaccharides results in increased expression of MB protein CTD PMID:20699433 lutein increases expression ISO RGD:1552831 6480464 Lutein results in increased expression of MB mRNA CTD PMID:24865317 methapyrilene increases methylation ISO RGD:1354197 6480464 Methapyrilene results in increased methylation of MB intron CTD PMID:30157460 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1552831 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MB mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1552831 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MB mRNA] CTD PMID:25566086 nickel atom decreases expression ISO RGD:1354197 6480464 Nickel results in decreased expression of MB mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:1354197 6480464 methyleugenol results in decreased expression of MB mRNA CTD PMID:32234424 ozone decreases expression ISO RGD:1552831 6480464 Ozone results in decreased expression of MB mRNA CTD PMID:12763052 paracetamol multiple interactions ISO RGD:1552831 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MB mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MB mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1552831 6480464 Acetaminophen results in increased expression of MB mRNA CTD PMID:17585979 perfluorononanoic acid increases expression ISO RGD:1354197 6480464 perfluoro-n-nonanoic acid results in increased expression of MB mRNA CTD PMID:25812627 perfluorooctanoic acid increases expression ISO RGD:1354197 6480464 perfluorooctanoic acid results in increased expression of MB mRNA CTD PMID:25812627 phenobarbital affects expression ISO RGD:1552831 6480464 Phenobarbital affects the expression of MB mRNA CTD PMID:23091169 pioglitazone multiple interactions ISO RGD:1552831 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MB mRNA CTD PMID:27935865 pluronic P-123 multiple interactions EXP 6480464 carvacrol inhibits the reaction [Poloxamer results in increased secretion of MB protein], Simvastatin inhibits the reaction [Poloxamer results in increased secretion of MB protein] CTD PMID:29071762 pluronic P-123 increases secretion EXP 6480464 Poloxamer results in increased secretion of MB protein CTD PMID:29071762 Poloxamer increases secretion EXP 6480464 Poloxamer results in increased secretion of MB protein CTD PMID:29071762 Poloxamer multiple interactions EXP 6480464 carvacrol inhibits the reaction [Poloxamer results in increased secretion of MB protein], Simvastatin inhibits the reaction [Poloxamer results in increased secretion of MB protein] CTD PMID:29071762 potassium dichromate increases expression ISO RGD:1552831 6480464 Potassium Dichromate results in increased expression of MB mRNA CTD PMID:23608068 rosuvastatin calcium affects expression EXP 6480464 Rosuvastatin Calcium affects the expression of MB protein CTD PMID:27815113 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1354197 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MB mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:1552831 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased secretion of MB protein CTD PMID:29679711 SB 431542 multiple interactions ISO RGD:1354197 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MB mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:1552831 6480464 Asbestos, Serpentine results in decreased expression of MB mRNA CTD PMID:21514415 serpentine asbestos multiple interactions ISO RGD:1552831 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos, Serpentine results in decreased expression of MB mRNA] CTD PMID:21514415 silicon dioxide decreases expression ISO RGD:1552831 6480464 Silicon Dioxide results in decreased expression of MB mRNA CTD PMID:29341224 silver atom decreases expression ISO RGD:1552831 6480464 Silver results in decreased expression of MB mRNA CTD PMID:19429238 silver(0) decreases expression ISO RGD:1552831 6480464 Silver results in decreased expression of MB mRNA CTD PMID:19429238 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Poloxamer results in increased secretion of MB protein] CTD PMID:29071762 sinapic acid multiple interactions EXP 6480464 sinapinic acid inhibits the reaction [Isoproterenol results in increased expression of MB protein] CTD PMID:32627257 sodium arsenite multiple interactions ISO RGD:1354197 6480464 [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of MB mRNA, [PRMT1 mutant form co-treated with sodium arsenite] results in increased expression of MB mRNA CTD PMID:23699174 sodium arsenite affects expression ISO RGD:1552831 6480464 sodium arsenite affects the expression of MB mRNA CTD PMID:17450228 sodium nitrate multiple interactions ISO RGD:1552831 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of MB protein] CTD PMID:21251210 succinylcholine increases secretion ISO RGD:1354197 6480464 Succinylcholine results in increased secretion of MB protein CTD PMID:8217179 sulforaphane decreases expression ISO RGD:1354197 6480464 sulforaphane results in decreased expression of MB mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1354197 6480464 Sunitinib results in decreased expression of MB mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1552831 6480464 Tamoxifen affects the expression of MB mRNA CTD PMID:17555576 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MB mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1552831 6480464 titanium dioxide results in decreased expression of MB mRNA CTD PMID:23557971 triamcinolone increases secretion EXP 6480464 Triamcinolone results in increased secretion of MB protein CTD PMID:19628585 triclosan decreases expression ISO RGD:1354197 6480464 Triclosan results in decreased expression of MB mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1552831 6480464 triptonide results in increased expression of MB mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1354197 6480464 Urethane results in increased expression of MB mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1354197 6480464 Valproic Acid results in decreased expression of MB mRNA CTD PMID:24935251 , PMID:29154799 very-low-density lipoprotein triglyceride multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [MB modified form results in decreased secretion of very low density lipoprotein triglyceride] CTD PMID:17478120 very-low-density lipoprotein triglyceride decreases secretion EXP 6480464 MB modified form results in decreased secretion of very low density lipoprotein triglyceride CTD PMID:17478120 vitamin E increases expression ISO RGD:1354197 6480464 Vitamin E results in increased expression of MB mRNA CTD PMID:19244175